FDA.reportPublic FDA data

Cheongin Haejanghwan

Manufacturer
Entechbio Co., Ltd
Effective date
2011-02-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:27:18

Label at a glance#

ProductCheongin Haejanghwan
Active ingredientLACTIC ACID
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

active ingredient: lactic acid (lactobacillus casei, lactobacillus bifidus)

INACTIVE INGREDIENT SECTION

inactive ingredient: GLYCINE, HOUTTUYNIA CORDATA FLOWERING TOP, ANGELICA GIGAS ROOT, GLYCYRRHIZA URALENSIS

OTC - PURPOSE SECTION

helps to promote intestine functions and boost metabolism
to reduce cholesterol and improve arteriosclerosis

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

take 1 packet with enough water after meal

WARNINGS SECTION

do not take if you have an idiosyncratic of allergic reaction symptom
do not take over 3 packet a day

DOSAGE & ADMINISTRATION SECTION

take continuously even if you feel improvement of physical constitution

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

package insert
package insert

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LACTIC ACID, UNSPECIFIED FORM Pharmacologic Class Indexing1Indexing - Pharmacologic Class20220121

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
75863-2001-12019-10-29C16284748780-1960f7f55-d12d-8e05-e053-dbdaa90a074aDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
75863-2001-1Cheongin Haejanghwan5 g in 1 PACKETPELLET51

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
75863-2001CHEONGIN HAEJANGHWAN (LACTIC ACID) PELLET [ENTECHBIO CO., LTD]1Legacy NDC, 1 package rows20110224_0ead4fc4-5a5a-4c86-83d4-e381e0c96a14.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
LACTIC ACIDACTIVE INGREDIENT33X04XA5AT1
LACTIC ACIDACTIVE MOIETY33X04XA5AT1
ANGELICA GIGAS ROOTINACTIVE INGREDIENT32766B2FHX1
GLYCINEINACTIVE INGREDIENTTE7660XO1C1
GLYCYRRHIZA URALENSISINACTIVE INGREDIENT42B5YD8F0K1
HOUTTUYNIA CORDATA FLOWERING TOPINACTIVE INGREDIENTRH041UUZ221

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
75863-200175863-2001-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
LACTIC ACID33X04XA5ATACTIB
GLYCINETE7660XO1CIACT
HOUTTUYNIA CORDATA FLOWERING TOPRH041UUZ22IACT
ANGELICA GIGAS ROOT32766B2FHXIACT
GLYCYRRHIZA URALENSIS42B5YD8F0KIACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 20 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
GLYCINEGLYCINETE7660XO1CCAPSULE, DELAYED RELEASE / ORAL50 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CSOLUTION / ORAL50 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, SOLUTION / INTRAVENOUS0.42 %w/vExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR40 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS3.76 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS10 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTABLE, LIPOSOMAL / INTRAVENOUS0.38 %w/vExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CPOWDER, FOR SOLUTION / ORAL0.09 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CPOWDER / RESPIRATORY (INHALATION)2 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CCAPSULE / ORAL62 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CTABLET, ORALLY DISINTEGRATING / ORAL60 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CTABLET / ORAL163.31 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CPOWDER, FOR SUSPENSION / ORAL400 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CPASTE, DENTIFRICE / DENTAL0.34 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CTABLET, CHEWABLE / ORAL267 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRADERMAL0.5 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION / INTRAMUSCULAR68 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS0.5 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION / INTRAVENOUS200 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS200 mgExact identifier — unii candidate
20 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8bc8211c-e3b9-4815-865d-3719847b12200ead4fc4-5a5a-4c86-83d4-e381e0c96a142011-02-18WarningsExact identifier
spl id: 8bc8211c-e3b9-4815-865d-3719847b1220
spl set id: 0ead4fc4-5a5a-4c86-83d4-e381e0c96a14

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.